|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
6
|
|
gptkbp:bfsParent
|
gptkb:Bio_Syn
|
|
gptkbp:acquisition
|
gptkb:Bio_Health_Inc.
|
|
gptkbp:awards
|
Best Biotech Company 2022
|
|
gptkbp:ceo
|
gptkb:John_E._Smith
|
|
gptkbp:clinical_trial
|
gptkb:healthcare_organization
gptkb:hospital
Immunology
Neurology
Phase 3
|
|
gptkbp:collaborations
|
gptkb:World_Health_Organization
gptkb:Research_Institute
|
|
gptkbp:community_engagement
|
Volunteer Work
Scholarship Programs
Local Schools
Health Fairs
|
|
gptkbp:employees
|
gptkb:500
|
|
gptkbp:founded
|
gptkb:2001
|
|
gptkbp:founder
|
gptkb:Jane_Doe
gptkb:Mark_Johnson
|
|
gptkbp:future_plans
|
gptkb:metropolitan_area
gptkb:Telecommunications_company
Talent Acquisition
Global Expansion
Innovative Therapies
New Partnerships
Expand Product Line
Increase Market Presence
Increase R& D Budget
Enhance Clinical Trials
|
|
gptkbp:headcount
|
500+
|
|
gptkbp:headquarters
|
gptkb:San_Diego,_California
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Global Biotech Corp
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:invention
|
50+
|
|
gptkbp:investment
|
Venture Capital Partners
|
|
gptkbp:market_cap
|
$1 billion
|
|
gptkbp:partnerships
|
gptkb:University_of_California
|
|
gptkbp:philanthropy
|
Health Initiatives
|
|
gptkbp:products
|
Biopharmaceuticals
|
|
gptkbp:research_areas
|
gptkb:Scripps_Research_Institute
|
|
gptkbp:research_focus
|
gptkb:Gene_Therapy
|
|
gptkbp:revenue
|
$200 million
|
|
gptkbp:services
|
gptkb:Research_Institute
|
|
gptkbp:social_responsibility
|
gptkb:healthcare_organization
Diversity and Inclusion
Environmental Stewardship
Ethical Research
|
|
gptkbp:subsidiary
|
Global Diagnostics
Global Therapeutics
|
|
gptkbp:sustainability
|
Green Practices
|
|
gptkbp:symbol
|
GBT
|
|
gptkbp:website
|
www.globalbiotech.com
|